ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 303 filers reported holding ALKERMES PLC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $338,585 | +8.9% | 12,088 | +21.7% | 0.01% | 0.0% |
| Q2 2023 | $310,997 | +15.6% | 9,936 | +4.1% | 0.01% | +25.0% |
| Q1 2023 | $269,017 | -16.2% | 9,543 | -22.3% | 0.00% | -20.0% |
| Q4 2022 | $320,903 | +7.3% | 12,281 | -8.2% | 0.01% | -16.7% |
| Q3 2022 | $299,000 | -33.6% | 13,384 | -11.4% | 0.01% | -25.0% |
| Q2 2022 | $450,000 | +11.7% | 15,101 | -1.4% | 0.01% | +14.3% |
| Q1 2022 | $403,000 | +9.8% | 15,309 | -3.0% | 0.01% | 0.0% |
| Q4 2021 | $367,000 | -1.3% | 15,777 | +31.1% | 0.01% | -12.5% |
| Q3 2021 | $372,000 | +37100.0% | 12,030 | +44455.6% | 0.01% | – |
| Q2 2021 | $1,000 | 0.0% | 27 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | – | 27 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 27 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 27 | -48.1% | 0.00% | – |
| Q4 2019 | $1,000 | – | 52 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |